Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma

Journal of Biosciences

Volumn 34, Issue 6, 2009, Pages 917-925

  Looi, Mee Lee ^a   Karsani, Saiful Anuar ^b,c   Rahman, Mariati Abdul ^a   Mohd Dali, Ahmad Zailani Hatta ^d   Md Ali, Siti Aishah ^d   Ngah, Wan Zurinah Wan ^d   Mohd Yusof, Yasmin Anum ^d  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

2D electrophoresis; Cervical cancer; CIN; Plasma proteomics

Indexed keywords

CLU PROTEIN, HUMAN; CLUSTERIN; CYTOKERATIN 19; LECTIN; PROTEOME; TETRANECTIN;

ARTICLE; BLOOD; CANCER STAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; PROTEOMICS; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CLUSTERIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; KERATIN-19; LECTINS, C-TYPE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PROTEOME; PROTEOMICS; UTERINE CERVICAL NEOPLASMS;

EID: 77949891426     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-009-0106-3     Document Type: Article

References (37)

1. Alaoui-Jamali M A and Xu Y J 2006 Proteomic technology for biomarker profiling in cancer: an update; J. Zhejiang Univ. Sci. B. 7 411-420
2. Bae S M, Lee C H, Cho Y L, Nam K H, Kim Y W, Kim C K, Han B D, Lee Y J et al. 2005 Two-dimensional gel analysis of protein expression profile in squamous cervical cancer patients; Gynecol. Oncol. 99 26-35
3. Barak V, Goike H, Panaretakis K W and Einarsson R 2004 Clinical utility of cytokeratins as tumor markers; Clin. Biochem. 37 529-540
4. Chen X, Halberg R B, Ehrhardt W M, Torrealba J and Dov, W F 2003 Clusterin as a biomarker in murine and human intestinal neoplasia; Pro.c Natl. Acad. Sci. USA 100 9530-9535
5. Coulombe P A and Omary M B 2002 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments; Curr. Opin. Cell Biol. 14 110-122
6. Criswell T, Klokov D, Beman M, Lavik J P and Boothman D A 2003 Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein; Cancer Biol. Ther. 2 372-380
7. Doustjalali S R, Yusof R, Yip C H, Looi L M, Pillay B and Hashim O H 2004 Aberrant expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors; Electrophoresis 25 2392-2401
8. Ferrero S, Gillott D J, Remorgida V, Anserini P, Price K, Ragni N and Grudzinskas J G 2005 Haptoglobin beta chain isoforms in the plasma and peritoneal fluid of women with endometriosis; Fertil. Steril. 83 1536-1543
9. Gianazza E, Eberini I, Villa P, Fratelli M, Pinna C, Wait R, Gemeiner M and Miller I 2002 Monitoring the effects of drug treatment in rat models of disease by serum protein analysis; J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 771 107-130
10. Hogdall C K, Christiansen M, Norgaard-Pedersen B, Bentzen S M, Kronborg O and Clemmensen I 1995 Plasma tetranectin and colorectal cancer; Eur. J. Cancer 31A 888-894
11. Holtet T L, Graversen J H, Clemmensen I, Thogersen H C and Etzerodt M 1997 Tetranectin, a trimeric plasminogen-binding C-type lectin; Protein Sci. 6 1511-1515
12. Itahara Y, Piens M, Sumida T, Fong S, Maschler J and Desprez P Y 2007 Regulation of clusterin expression in mammary epithelial cells; Exp. Cell Res. 313 943-951
13. Kang Y K, Hong S W, Lee H and Kim W H 2004 Overexpression of clusterin in human hepatocellular carcinoma; Hum. Pathol. 35 1340-1346
14. Kurahashi T, Muramaki M, Yamanaka K, Hara I and Miyake, H 2005 Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension; BJU Int. 96 895-899
15. Marceau N, Schutte B, Gilbert S, Loranger A, Henfling M E, Broers J L, Mathew J and Ramaekers F C 2007 Dual roles of intermediate filaments in apoptosis; Exp. Cell Res. 313 2265-2281
16. Mogues T, Etzerodt M, Hall C, Engelich G, Graversen J H and Hartshorn K L 2004 Tetranectin binds to the kringle 1-4 form of angiostatin and modifies its functional activity; J. Biomed. Biotechnol. 2004 73-78
17. MOH 1999 National health and morbidity survey 1996 (Malaysia: Ministry of Health)
18. Nijhuis E R, Reesink-Peters N, Wisman G B, Nijman H W, van Zanden J, Volders H, Hollema H, Suurmeijer A J et al. 2006 An overview of innovative techniques to improve cervical cancer screening; Cell Oncol. 28 233-246
19. Oshima R G 2002 Apoptosis and keratin intermediate filaments; Cell Death Differ. 9 486-492
20. Pawlik T M, Hawke D H, Liu Y, Krishnamurthy S, Fritsche H, Hunt K K and Kuerer H M 2006 Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein; BMC Cancer 6 68
21. Petignat P and Roy M 2007 Diagnosis and management of cervical cancer; BMJ 335 765-768
22. Pins M R, Fiadjoe J E, Korley F, Wong M, Rademaker A W, Jovanovic B, Yoo T K, Kozlowski J M et al. 2004 Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report; Prostate Cancer Prostatic Dis. 7 243-248
23. Reddington J J, Reddington G M and MacLachlan N J 1991 A competitive ELISA for detection of antibodies to the group antigen of bluetongue virus; J. Vet. Diagn. Invest. 3 144-147
24. Shannan B, Seifert M, Boothman D A, Tilgen W and Reichrath J 2006 Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control; J. Mol. Histol. 37 183-188
25. Shepherd J H 1996 Cervical and vulva cancer: changes in FIGO definitions of staging; Br. J. Obstet. Gynaecol. 103 405-406
26. Somiari R I, Somiari S, Russell S and Shriver C D 2005 Proteomics of breast carcinoma; J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 815 215-225
27. Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, Yu D, Ricci S, el-Deiry W et al. 2004 Myctransformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo; Cancer Res. 64 3126-3136
28. Tjalma W A, Van Waes T R, Van den Eeden, L E and Bogers J J 2005 Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix; Best Pract. Res. Clin. Obstet. Gynaecol. 19 469-483
29. Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Hai S, Ono K et al. 2006 Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma; J. Hepatobiliary Pancreat. Surg. 13 239-244
30. Winarti A Shame, anxiety keep women from taking Pap test The Jakarta Post 17 March 2008
31. Xin Z Y, Yu Z G, Wang T C, Hui X, Gou W L, Sun J, Qi H and Li R X 2005 Identification and quantification of the toxic dinoflagellate Gymnodinium sp. with competitive enzymelinked immunosorbent assay (cELISA); Harmful Algae 4 297-307
32. Yan J X, Wait R, Berkelman T, Harry R A, Westbrook J A, Wheeler C H and Dunn M J 2000 A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry; Electrophoresis 21 3666-3672
33. Ye B, Cramer D W, Skates S J, Gygi S P, Pratomo V, Fu L, Horick N K, Licklider L J et al. 2003 Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry; Clin. Cancer Res. 9 2904-2911
34. Yong P H, Junit S M, Harun F and Hashim O H 2006 Patients with congenital hypothyroidism demonstrate different altered expression of plasma fibrinogen and haptoglobin polypeptide chains; Clin. Biochem. 39 126-132
35. Yuan C C, Huang H C, Tsai L C, Ng H T and Huang T S 1997 Cytokeratin-19 associated with apoptosis and chemosensitivity in human cervical cancer cells; Apoptosis 2 101-105
36. Yuan C C, Huang T S, Ng H T, Liu R S, Hung M W and Tsai L C 1998 Elevated cytokeratin-19 expression associated with apoptotic resistance and malignant progression of human cervical carcinoma; Apoptosis 3 161-169
37. Zhao C, Annamalai L, Guo C, Kothandaraman N, Koh S C, Zhang H, Biswas A and Choolani M 2007 Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer; Neoplasia 9 1-7